ArticleInternational journal of molecular sciences2026
Antioxidant Astaxanthin Co-Treatment Protects Zebrafish from Dimethomorph-Induced Cardiovascular Toxicity.
Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dimethomorph (DIM) is a commonly applied morpholine fungicide, yet its potential toxicity to non-target organisms raises significant environmental concerns. This study aims to elucidate the toxicological effects of DIM on zebrafish, with a particular focus on its cardiovascular impacts. Zebrafish embryos were exposed to a range of DIM concentrations for 48 h, and their cardiac and vascular performance was meticulously assessed to determine the extent of cardiovascular toxicity. The findings revealed notable cardiac hypertrophy, evidenced by a substantial enlargement in heart size, alongside a dose-dependent reduction in heart rate. These observations suggest direct impairment of cardiac function following DIM exposure. To further investigate the molecular underpinnings of these effects, gene expression analysis was conducted using quantitative real-time PCR (qRT-PCR). The results demonstrated significant alterations in the expression of key genes associated with cardiovascular development and function, providing mechanistic insights into DIM's toxic effects. In addition to cardiac abnormalities, DIM exposure led to a significant increase in the metabolic rate of the zebrafish embryos, indicating a potential disruption in energy homeostasis. To explore possible protective measures, a rescue experiment was performed using Astaxanthin, a potent antioxidant. Notably, Astaxanthin treatment partially mitigated the observed cardiac and metabolic phenotypes, suggesting its potential as a therapeutic agent to counteract DIM-induced toxicity. In summary, this study provides compelling evidence of the cardiovascular toxicity of DIM in zebrafish, highlighting its potential to disrupt cardiac function and metabolic regulation. The observed effects underscore the importance of re-evaluating the environmental impact of DIM and emphasize the need for further research to fully understand its mechanisms of toxicity. The findings also suggest that Astaxanthin (AST) could serve as a protective agent against DIM-induced toxicity, opening avenues for future studies aimed at mitigating the adverse effects of this widely used fungicide. This research study contributes to the growing body of knowledge on the environmental and health risks associated with pesticide use, advocating for more stringent regulations and safer alternatives.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.